Document is current
Any future updates will be listed below
-
Authors
Liu, Chang
Dou, Xiaoyang
Zhao, Yutao
Zhang, Linda
Zhang, Lisheng https://orcid.org/0000-0003-1872-9978
Dai, Qing https://orcid.org/0000-0002-8578-1568
Liu, Jun https://orcid.org/0000-0002-2498-9963
Wu, Tong https://orcid.org/0000-0001-9968-9909
Xiao, Yu
He, Chuan https://orcid.org/0000-0003-4319-7424
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (R01 HL155909)
- License Information
-
More Information
Article History
Received: 24 August 2023
Accepted: 11 August 2024
First Online: 28 August 2024
Change Date: 27 February 2025
Change Type: Update
Change Details: This article was originally published under a CC BY-NC-ND 4.0 license, but has now been made available under a Creative Commons Attribution 4.0 International License (
Change Details: https://creativecommons.org/licenses/by/4.0/
Change Details: ), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. license. The PDF and HTML versions of the paper have been modified accordingly.
Competing interests
: C.H. is a scientific founder, a member of the scientific advisory board and equity holder of Aferna Bio, Inc. and Ellis Bio, Inc., a scientific cofounder and equity holder of Accent Therapeutics, Inc., and a member of the scientific advisory board of Rona Therapeutics and Element Biosciences. The remaining authors declare no competing interests.
